manilatimes17 小时
Eterna Therapeutics Announces Appointment of Dr. Elena Ratner to Board of Directors
CAMBRIDGE, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the ...
Morning coffee tied to lower death risk
A new study reveals that timing—more than quantity—might be the secret to coffee’s heart benefits. There’s good news for ...
manilatimes8 小时
Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts
Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, ...
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...
Rigel Pharmaceuticals, Inc.: Rigel Announces R289 Granted Orphan Drug Designation by the ...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...